Storia in 3 fonti

Definium Therapeutics, Inc. Announces Pricing of $700 Million Upsized Public Offering

Definium Therapeutics, Inc. Announces Pricing of $700 Million Upsized Public Offering

Raccontata dabenzinga.comzerohedge.commorningstar.com

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

morningstar.com2 g fa

Definium Therapeutics, Inc. Announces Proposed Public Offering

Definium Therapeutics launches $500M public offering to fund DT120 ODT, a psychedelic-assisted therapeutic for psychiatric and neurological disorders. The capital raise signals biotech-backed psychedelic therapy as an emerging market category for healthcare-focused investors.

Leggi questa versione → originale

benzinga.com1 g fa

What's Going On With Definium Therapeutics Stock Tuesday? - Definium Therapeutics (NASDAQ:DFTX)

Definium Therapeutics (DFTX) stock hits $38.24 after positive clinical data, but an 84.57 RSI signals the shares are currently overbought.

Leggi questa versione → originale

zerohedge.com2 g fa

Definium Soars As Much As 50% After LSD-Based Depression Drug Meets Late-Stage Clinical Trial Goal

DT120, a psychedelic that activates serotonin receptors, was generally well tolerated, with mostly mild side effects occurring on dosing day and no serious safety concerns.

Leggi questa versione → originale

Timeline cronologica

1. lunedì 22 giugno 2026·benzinga.com
   

   Definium Shares Soar After Reporting Positive Phase 3 Results For Single-Dose Depression Treatment - Defi

   Definium shares are surging Monday after the company announced positive topline results from its Phase 3 Emerge study evaluating DT120 orally disintegrating tablet in adults with…

2. lunedì 22 giugno 2026·zerohedge.com
   

   Definium Soars As Much As 50% After LSD-Based Depression Drug Meets Late-Stage Clinical Trial Goal

   DT120, a psychedelic that activates serotonin receptors, was generally well tolerated, with mostly mild side effects occurring on dosing day and no serious safety concerns.

3. lunedì 22 giugno 2026·morningstar.com
   

   Definium Therapeutics, Inc. Announces Proposed Public Offering

   Definium Therapeutics, Inc. Announces Proposed Public Offering

4. martedì 23 giugno 2026·benzinga.com
   

   What's Going On With Definium Therapeutics Stock Tuesday? - Definium Therapeutics (NASDAQ:DFTX)

   Definium Therapeutics (DFTX) stock hits $38.24 after positive clinical data, but an 84.57 RSI signals the shares are currently overbought.

5. mercoledì 24 giugno 2026·morningstar.com
   

   Definium Therapeutics, Inc. Announces Pricing of $700 Million Upsized Public Offering

   Definium Therapeutics, Inc. Announces Pricing of $700 Million Upsized Public Offering